Intravenous cyclosporine kinetics in renal failure

Kinetics of the novel immunosuppressive cyclosporine were determined in four patients with terminal renal failure. After a short intravenous infusion (2.05 to 3.5 mg/kg in 4 hr), blood and plasma concentrations were measured (HPLC and radioimmunoassay [RIA]) up to 36 hr. After infusion, concentration curves of the drug were characterized by a rapid initial fall (t 1 2α 0.10 ± 0.03 hr), followed by a biphasic elimination phase with corresponding t 1 2S of 1.08 ± 0.25 hr (t 1 2β) and 15.8 ± 8.4 hr (t 1 2γ). The volumes of distribution, calculated from whole blood concentrations (HPLC), were 0.140 ± 0.48 l/kg (volume of the central compartment) and 3.49 ± 2.65 l/kg (volume of distribution at steady state), whereas systemic clearances were 0.369 ± 0.08 l/hr/kg. Blood levels measured by RIA exceeded the HPLC values after the fourth hour by up to 100%, indicating the production of cross-reacting cyclosporine metabolites. Plasma concentrations were considerably lower than in whole blood. Elimination of unchanged cyclosporine in patients with renal failure appears to be of the same order as in those with normal kidney function. Modification of the initial dosage regimens is therefore probably not required.